Search

Your search keyword '"Lee, Moon Hee"' showing total 635 results
Start Over Author "Lee, Moon Hee"
635 results on '"Lee, Moon Hee"'

2. A gain-of-function p53 mutant synergizes with oncogenic NRAS to promote acute myeloid leukemia in mice

Author

Rajagopalan, Adhithi, Feng, Yubin, Gayatri, Meher B., Ranheim, Erik A., Klungness, Taylor, Matson, Daniel R., Lee, Moon Hee, Jung, Mabel Minji, Zhou, Yun, Gao, Xin, Nadiminti, Kalyan V.G., Yang, David T., Tran, Vu.L., Padron, Eric, Miyamoto, Shigeki, Bresnick, Emery H., and Zhang, Jing

Subjects
Gene mutations -- Health aspects, Gene expression -- Analysis, RNA sequencing -- Analysis, Hematopoietic stem cells -- Transplantation, Health care industry
Abstract

We previously demonstrated that a subset of acute myeloid leukemia (AML) patients with concurrent RAS pathway and TP53 mutations have an extremely poor prognosis and that most of these TP53 mutations are missense mutations. Here, we report that, in contrast to the mixed AML and T cell malignancy that developed in [Nras.sup.G12D/+] [p53.sup.-/-] ([NP.sup.-/- ]) mice, [Nras.sup.G120/+] [p53.sup.R172H/+] ([NP.sup.mut]) mice rapidly developed inflammation-associated AML. Under the inflammatory conditions, [NP.sup.mut] hematopoietic stem and progenitor cells (HSPCs) displayed imbalanced myelopoiesis and lymphopoiesis and mostly normal cell proliferation despite MEK/ERK hyperactivation. RNA-Seq analysis revealed that oncogenic NRAS signaling and mutant p53 synergized to establish an [NP.sup.mut]-AML transcriptome distinct from that of [NP.sup.-/-] cells. The [NP.sup.mut]-AML transcriptome showed GATA2 downregulation and elevated the expression of inflammatory genes, including those linked to NF-[kappa]B signaling. NF- [kappa]B was also upregulated in human NRAS TP53 AML. Exogenous expression of GATA2 in human [NP.sup.mut] KY821 AML cells downregulated inflammatory gene expression. Mouse and human [NP.sup.mut] AML cells were sensitive to MEK and NF- [kappa]B inhibition in vitro. The proteasome inhibitor bortezomib stabilized the NF-KB-inhibitory protein iKBa, reduced inflammatory gene expression, and potentiated the survival benefit of a MEK inhibitor in [NP.sup.mut] mice. Our study demonstrates that a p53 structural mutant synergized with oncogenic NRAS to promote AML through mechanisms distinct from p53 loss., Introduction Acute myeloid leukemia (AML) is an aggressive and devastating hematologic malignancy characterized by the accumulation of partially differentiated myeloid blast cells ([greater than or equal to]20%) in bone marrow [...]

Published
2023
Full Text
View/download PDF

3. 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE

Author

Loualidi, Ab, Colak, Abdurrahim, Bezuidenhout, Abraham, Abdool-Carrim, Abu, Azeddine, Addala, Beyers, Adriaan, Dees, Adriaan, Mohamed, Ahmed, Aksoy, Ahmet, Abiko, Akihiko, Watanabe, Akinori, Krichell, Alan, Fernandez, Alberto Alfredo, Tosetto, Alberto, Khotuntsov, Alexey, Oropallo, Alisha, Slocombe, Alison, Kelly, Allan, Clark, Amanda, Gad, Amr, Arouni, Amy, Schmidt, Andor, Berni, Andrea, Kleiban, Andres Javier, Machowski, Andrew, Kazakov, Andrey, Galvez, Angel, Lockman, Ann, Falanga, Anna, Chauhan, Anoop, Riera-Mestre, Antoni, Mazzone, Antonino, D'Angelo, Armando, Herdy, Artur, Kato, Atsushi, Salem, Ayman Abd Elhamid Ebrahim Mahmoud, Husin, Azlan, Erdelyi, Barbara, Jacobson, Barry, Amann-Vesti, Beatrice, Battaloglu, Bektas, Wilson, Benedicte, Cosmi, Benilde, Francois, Bergmann Jean, Toufek, Berremeli, Hunt, Beverley, Natha, Bhavesh, Mustafa, Bisher, Kho, Bonnie Chi Shan, Carine, Boulon, Zidel, Brian, Dominique, Brisot, Christophe, Brousse, Trimarco, Bruno, Luo, Canhua, Cuneo, Carlos Alberto, Diaz, Carlos Jerjes Sanchez, Schwencke, Carsten, Cader, Cas, Yavuz, Celal, Zaidman, Cesar Javier, Lunn, Charles, Wu, Chau-Chung, Toh, Cheng Hock, Chiang, Chern-En, Elisa, Chevrier, Hsia, Chien-Hsun, Huang, Chien-Lung, Kwok, Chi-Hang Kevin, Wu, Chih-Cheng, Huang, Chi-Hung, Ward, Chris, Opitz, Christian, Jeanneret-Gris, Christina, Ha, Chung Yin, Huang, Chun-Yao, Bidi, Claude Luyeye, Smith, Clifford, Brauer, Cornelia, Lodigiani, Corrado, Francis, Couturaud, Wu, Cynthia, Staub, Daniel, Theodoro, Daniel, Poli, Daniela, Acevedo, David - Riesco, Adler, David, Jimenez, David, Keeling, David, Scott, David, Imberti, Davide, Creagh, Desmond, Helene, Desmurs-Clavel, Hagemann, Dirk, Le Roux, Dirk, Skowasch, Dirk, Belenky, Dmitry, Dorokhov, Dmitry, Petrov, Dmitry, Zateyshchikov, Dmitry, Prisco, Domenico, Møller, Dorthe, Kucera, Dusan, Esheiba, Ehab M., Panchenko, Elizaveta, Dominique, Elkouri, Dogan, Emre, Kubat, Emre, Diaz, Enrique Diaz, Tse, Eric Wai Choi, Yeo, Erik, Hashas, Erman, Grochenig, Ernst, Tiraferri, Eros, Blessing, Erwin, Michèle, Escande Orthlieb, Usandizaga, Esther, Porreca, Ettore, Ferroni, Fabian, Nicolas, Falvo, Ayala-Paredes, Félix, Koura, Firas, Henry, Fitjerald, Cosmi, Franco, Erdkamp, Frans, Kamalov, Gadel, Dalmau, Garcia-Bragado, Damien, Garrigues, Klein, Garry, Shah, Gaurand, Hollanders, Geert, Merli, Geno, Plassmann, Georg, Platt, George, Poirier, Germain, Sokurenko, German, Haddad, Ghassan, Ali, Gholam, Agnelli, Giancarlo, Gan, Gin Gin, Kaye-Eddie, Grace, Le Gal, Gregoire, Allen, Gregory, Esperón, Guillermo Antonio Llamas, Jean-Paul, Guillot, Gerofke, Hagen, Elali, Hallah, Burianova, Hana, Ohler, Hans-Juergen, Wang, Haofu, Darius, Harald, Gogia, Harinder S., Striekwold, Harry, Gibbs, Harry, Hasanoglu, Hatice, Turker, Hatice, Franow, Hendrik, Bounameaux, Henri, De Raedt, Herbert, Schroe, Herman, ElDin, Hesham Salah, Zidan, Hesham, Nakamura, Hiroaki, Kim, Ho Young, Lawall, Holger, Zhu, Hong, Tian, Hongyan, Yhim, Ho-Young, ten Cate, Hugo, Hwang, Hun Gyu, Shim, Hyeok, Kim, Igor, Libov, Igor, Sonkin, Igor, Suchkov, Igor, Song, Ik-Chan, Kiris, Ilker, Staroverov, Ilya, Looi, Irene, De La Azuela Tenorio, Isabel M., Savas, Ismail, Gordeev, Ivan, Podpera, Ivo, Lee, Jae Hoon, Sathar, Jameela, Welker, James, Beyer-Westendorf, Jan, Kvasnicka, Jan, Vanwelden, Jan, Kim, JangYong, Svobodova, Jaromira, Gujral, Jaspal, Marino, Javier, Galvar, Javier Tristan, Kassis, Jeannine, Kuo, Jen-Yuan, Shih, Jhih-Yuan, Kwon, JiHyun, Joh, Jin Hyun, Park, Jin Hyun, Kim, Jin Seok, Yang, Jinghua, Krupicka, Jiri, Lastuvka, Jiri, Pumprla, Jiri, Vesely, Jiri, Souto, Joan Carlos, Correa, João Antônio, Duchateau, Johan, Fletcher, John Perry, del Toro, Jorge, Paez, Jorge Guillermo Chavez, Nielsen, Jørn, Filho, Jose Dalmo Araujo, Saraiva, Jose, Peromingo, Jose Antonio Diaz, Lara, Jose Gomez, Fedele, Jose Luis, Surinach, Jose Maria, Chacko, Joseph, Muntaner, Juan Antonio, Benitez, Juan Carlos Álvarez, Abril, Juan Moreno Hoyos, Humphrey, Julian, Bono, Julio, Kanda, Junji, Boondumrongsagoon, Juree, Yiu, Kai Hang, Chansung, Kanchana, Boomars, Karin, Burbury, Kate, Kondo, Katsuhiro, Karaarslan, Kemal, Takeuchi, Kensuke, Kroeger, Knut, Zrazhevskiy, Konstantin, Svatopluk, Koscál, Shyu, Kou-Gi, Vandenbosch, Kristel, Chang, Kuan-Cheng, Chiu, Kuan-Ming, Jean-Manuel, Kubina, Wern, Kwan Jing, Ueng, Kwo-Chang, Norasetthada, Lalita, Binet, Laure, Chew, Lee Ping, Zhang, Lei, Cristina, Leone Maria, Tick, Lidwine, Schiavi, Lilia Beatriz, Wong, Lily Lee Lee, Borges, Lohana, Botha, Louis, Capiau, Luc, Timmermans, Luc, López, Luciano Eduardo, Ria, Luigi, Blasco, Luis Manuel Hernandez, Guzman, Luis Alberto, Cervera, Luis Flota, Isabelle, Mahe, Bosch, Manuel Monreal, de los Rios Ibarra, Manuel, Fernandez, Manuel Núñez, Carrier, Marc, Barrionuevo, Marcelo Raul, Gamba, Marco Antonio Alcocer, Cattaneo, Marco, Moia, Marco, Bowers, Margaret, Chetanachan, Mariam, Berli, Mario Alberto, Fixley, Mark, Faghih, Markus, Stuecker, Markus, Schul, Marlin, Banyai, Martin, Koretzky, Martin, Myriam, Martin, Gaffney, Mary Elizabeth, Hirano, Masao, Kanemoto, Masashi, Nakamura, Mashio, Tahar, Mersel, Emmanuel, Messas, Kovacs, Michael, Leahy, Michael, Levy, Michael, Munch, Michael, Olsen, Michael, De Pauw, Michel, Gustin, Michel, Van Betsbrugge, Michiel, Boyarkin, Mikhail, Homza, Miroslav, Koto, Modise, Abdool-Gaffar, Mohamed, Nagib, Mohamed Ayman Fakhry, El-Dessoki, Mohamed, Khan, Mohamed, Mohamed, Monniaty, Kim, Moo Hyun, Lee, Moon-Hee, Soliman, Mosaad, Ahmed, Mostafa Shawky, el Bary, Mostafa Soliman Abd, Moustafa, Moustafa A., Hameed, Muhammad, Kanko, Muhip, Majumder, Mujibur, Zubareva, Nadezhda, Mumoli, Nicola, Abdullah, Nik Azim Nik, Makruasi, Nisa, Paruk, Nishen, Kanitsap, Nonglak, Duda, Norberto, Nordin, Nordiana, Nyvad, Ole, Barbarash, Olga, Gurbuz, Orcun, Vilamajo, Oscar Gomez, Flores, Oscar Nandayapa, Gur, Ozcan, Oto, Oztekin, Marchena, Pablo Javier, Angchaisuksiri, Pantep, Carroll, Patrick, Lang, Pavel, MacCallum, Peter, von Bilderling, Peter Baron, Blombery, Peter, Verhamme, Peter, Jansky, Petr, Bernadette, Peuch, De Vleeschauwer, Philippe, Hainaut, Philippe, Ferrini, Piera Maria, Iamsai, Piriyaporn, Christian, Ponchaux, Viboonjuntra, Pongtep, Rojnuckarin, Ponlapat, Ho, Prahlad, Mutirangura, Pramook, Wells, Rachel, Martinez, Rafael, Miranda, Raimundo Tirado, Kroening, Ralf, Ratsela, Rapule, Reyes, Raquel Lopez, de Leon, Raul Franco Diaz, Wong, Raymond Siu Ming, Alikhan, Raz, Jerwan-Keim, Reinhold, Otero, Remedios, Murena-Schmidt, Renate, Canevascini, Reto, Ferkl, Richard, White, Richard, Van Herreweghe, Rika, Santoro, Rita, Klamroth, Robert, Mendes, Robert, Prosecky, Robert, Cappelli, Roberto, Spacek, Rudolf, Singh, Rupesh, Griffin, Sam, Na, Sang Hoon, Chunilal, Sanjeev, Middeldorp, Saskia, Nakazawa, Satoshi, Schellong, Sebastian, Toh, See Guan, Christophe, Seinturier, Isbir, Selim, Raymundo, Selma, Ting, Seng Kiat, Motte, Serge, Aktogu, Serir Ozkan, Donders, Servaas, Cha, Seung Ick, Nam, Seung-Hyun, Marie-Antoinette, Sevestre-Pietri, Maasdorp, Shaun, Sun, Shenghua, Wang, Shenming, Essameldin, Sherif Mohamed, Sholkamy, Sherif Mohamed, Kuki, Shintaro, Goto, Shinya, Yoshida, Shuichi, Matsuoka, Shunzo, McRae, Simon, Watt, Simon, Patanasing, Siriwimon, Jean-Léopold, Siwe-Nana, Wongkhantee, Somchai, Bang, Soo-Mee, Testa, Sophie, Zemek, Stanislav, Behrens, Steffen, Dominique, Stephan, Mellor, Stuart, Singh, Suaran Singh Gurcharan, Datta, Sudip, Chayangsu, Sunee, Solymoss, Susan, Everington, Tamara, Abdel-Azim, Tarek Ahmed Adel, Suwanban, Tawatchai, Adademir, Taylan, Hart, Terence, Béatrice, Terriat, Luvhengo, Thifhelimbilu, Horacek, Thomas, Zeller, Thomas, Boussy, Tim, Reynolds, Tim, Biss, Tina, Chao, Ting-Hsing, Casabella, Tomas Smith, Onodera, Tomoya, Numbenjapon, Tontanai, Gerdes, Victor, Cech, Vladimir, Krasavin, Vladimir, Tolstikhin, Vladimir, Bax, W.A., Malek, Wagih Fawzy Abdel, Ho, Wai Khoon, Ageno, Walter, Pharr, Walter, Jiang, Weihong, Lin, Wei-Hsiang, Zhang, Weihua, Tseng, Wei-Kung, Lai, Wen-Ter, De Backer, Wilfried, Haverkamp, Wilhelm, Yoshida, Winston, Korte, Wolfgang, Choi, Won Il, Kim, Yang-Ki, Tanabe, Yasuhiro, Ohnuma, Yasushi, Mun, Yeung-Chul, Balthazar, Yohan, Park, Yong, Shibata, Yoshisato, Burov, Yuriy, Subbotin, Yuriy, Coufal, Zdenek, Yang, Zhenwen, Jing, Zhicheng, Yang, Zhongqi, Turpie, Alexander G.G., Farjat, Alfredo E., Haas, Sylvia, Weitz, Jeffrey I., Goldhaber, Samuel Z., Kayani, Gloria, Lopes, Renato D., Tse, Eric, Muntaner, Juan, Prandoni, Paolo, Maheshwari, Uma, and Kakkar, Ajay K.

Published
2023
Full Text
View/download PDF

4. Palbociclib plus exemestane with GnRH agonist vs capecitabine in premenopausal patients with HR+/HER2- metastatic breast cancer: Updated survival results of the randomized phase 2 study Young-PEARL.

Author

Park, Yeon Hee, primary, Lee, Kyung-Hun, additional, Kim, Gun Min, additional, Kang, Seok Yun, additional, Lee, Keun Seok, additional, Kim, Jee Hyun, additional, Lee, Kyoung Eun, additional, Ahn, Hee Kyung, additional, Lee, Moon Hee, additional, Kim, Hee Jun, additional, Kim, Hanjo, additional, Koh, Su-Jin, additional, Kim, Ji-Yeon, additional, Sohn, Joohyuk, additional, Kim, Sung-Bae, additional, Ahn, Jin Seok, additional, Kim, Seonwoo, additional, Cho, Hyun, additional, Jung, Kyung Hae, additional, and Im, Seock-Ah, additional

Published
2024
Full Text
View/download PDF

5. Patient-derived tumor explant models of tumor immune microenvironment reveal distinct and reproducible immunotherapy responses

Author

Turpin, Rita, primary, Peltonen, Karita, additional, Rannikko, Jenna H, additional, Liu, Ruixian, additional, Kumari, Anita N, additional, Nicorici, Daniel, additional, Lee, Moon Hee, additional, Mutka, Minna, additional, Kovanen, Panu E, additional, Niinikoski, Laura, additional, Meretoja, Tuomo, additional, Mattson, Johanna, additional, Järvinen, Petrus, additional, Lahdensuo, Kanerva, additional, Järvinen, Riikka, additional, Tornberg, Sara, additional, Mirtti, Tuomas JK, additional, Boström, Pia, additional, Koskivuo, Ilkka, additional, Thotakura, Anil, additional, Pouwels, Jeroen, additional, Hollmén, Maija, additional, Mustjoki, Satu, additional, and Klefström, Juha, additional

Published
2024
Full Text
View/download PDF

8. The significance of Fas, tumor necrosis factor-related apoptosis-inducing ligand and fibrinolytic factors in the assessment of malignant pleural effusion

Author

Choi Jong Weon, Lee Moon Hee, and Fujii Tatsuyoshi

Subjects
pleural effusion, apoptosis, malignancy, fibrinolytic factor, fas, trail, Biology (General), QH301-705.5
Abstract

Few studies have examined the usefulness of soluble apoptotic markers for the screening of pleural effusion. This study aimed to investigate the significance of Fas, tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and fibrinolytic factors for the assessment of patients with malignant pleural effusion. A total of 137 patients with pleural effusion were evaluated. Soluble Fas, TRAIL, tissue-type plasminogen activator (tPA), plasminogen activator inhibitor-1 (PAI-1), D-dimers and lactate dehydrogenase (LD) levels were measured. Pleural fluid/blood (P/B) ratios of fibrinolytic factors were calculated. Fas and TRAIL levels were significantly higher in patients with malignant effusion than in those with non-malignant effusion. Malignant effusion was 1.6-fold more prevalent in patients with elevated Fas than in those without (48.5% vs 30.4%, P=0.031). The P/B ratio of tPA was 2.5-fold higher in malignant effusion than in non-malignant effusion (4.65 vs 1.83, P

Published
2022
Full Text
View/download PDF

10. Single-cell characterization of anti-LAG-3 and anti-PD-1 combination treatment in patients with melanoma

Author

Huuhtanen, Jani, Kasanen, Henna, Peltola, Katriina, Lonnberg, Tapio, Glumoff, Virpi, Bruck, Oscar, Dufva, Olli, Peltonen, Karita, Vikkula, Johanna, Jokinen, Emmi, Ilander, Mette, Lee, Moon Hee, Makela, Siru, Nyakas, Marta, Li, Bin, Hernberg, Micaela, Bono, Petri, Lahdesmaki, Harri, Kreutzman, Anna, and Mustjoki, Satu

Subjects
Drug therapy, Combination -- Methods, Immunotherapy -- Methods, Melanoma -- Care and treatment, Health care industry
Abstract

BACKGROUND. Relatlimab plus nivolumab (anti-lymphocyte-activation gene 3 plus anti-programmed death 1 [anti- [LAG3.sup.+]anti-PD-1]) has been approved by the FDA as a first-line therapy for stage III/IV melanoma, but its detailed effect on the immune system is unknown. METHODS. We evaluated blood samples from 40 immunotherapy-naive or prior immunotherapy-refractory patients with metastatic melanoma treated with anti-LAG-3+anti-PD-1 in a phase I trial using single-cell RNA and T cell receptor sequencing (scRNA+TCR[alpha][beta]-Seq) combined with other multiomics profiling. RESULTS. The highest LAG3 expression was noted in NK cells, Tregs, and [CD8.sup.+] T cells, and these cell populations underwent the most significant changes during the treatment. Adaptive NK cells were enriched in responders and underwent profound transcriptomic changes during the therapy, resulting in an active phenotype. [LAG3.sup.+] Tregs expanded, but based on the transcriptome profile, became metabolically silent during the treatment. Last, higher baseline TCR clonality was observed in responding patients, and their expanding [CD8.sup.+] T cell clones gained a more cytotoxic and NK-like phenotype. CONCLUSION. Anti-LAG-3+anti-PD-1 therapy has profound effects on NK cells and Tregs in addition to [CD8.sup.+] T cells. TRIAL REGISTRATION. ClinicalTrials.gov (NCT01968109) FUNDING. Cancer Foundation Finland, Sigrid Juselius Foundation, Signe and Ane Gyllenberg Foundation, Relander Foundation, State funding for university-level health research in Finland, a Helsinki Institute of Life Sciences Fellow grant, Academy of Finland (grant numbers 314442, 311081, 335432, and 335436), and an investigator-initiated research grant from BMS., Introduction Even though immune checkpoint inhibitor therapies have revolutionized the treatment of metastatic melanoma, a majority of patients fail to achieve sustainable responses. As currently available immune checkpoint inhibitor therapies [...]

Published
2023
Full Text
View/download PDF

11. Non-Metastatic Clear Cell Renal Cell Carcinoma Immune Cell Infiltration Heterogeneity and Prognostic Ability in Patients Following Surgery

Author

Shapiro, Daniel D., primary, Lozar, Taja, additional, Cheng, Lingxin, additional, Xie, Elliot, additional, Laklouk, Israa, additional, Lee, Moon Hee, additional, Huang, Wei, additional, Jarrard, David F., additional, Allen, Glenn O., additional, Hu, Rong, additional, Kinoshita, Toshi, additional, Esbona, Karla, additional, Lambert, Paul F., additional, Capitini, Christian M., additional, Kendziorski, Christina, additional, and Abel, Edwin Jason, additional

Published
2024
Full Text
View/download PDF

13. OP02-1 Safety and efficacy of eribulin in patients with advanced or metastatic breast cancer previously treated with anthracycline and taxane in real-world clinical practice: Data from post-marketing surveillance in Korea

Author

Chae, Yee Soo, primary, Kwon, Kyung A., additional, Lee, Moon Hee, additional, Ahn, Mi Sun, additional, Lee, Kyung-Hun, additional, Koh, Su-Jin, additional, Sohn, Joohyuk, additional, Park, Keon Uk, additional, Kim, Min Young, additional, Pyo, Youngji, additional, Kim, Bo Young, additional, and Jung, Kyung Hae, additional

Published
2023
Full Text
View/download PDF

15. Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial

Author

Ahn, HK, Cho, EK, Park, IH, Lee, KS, Sim, SS, Hong, SJ, Chang, MH, Kim, JH, Kim, YJ, Kim, SH, Suh, KJ, Park, YH, Park, WY, Choi, YL, Yu, JH, Im, YH, Ahn, JS, Hur, JY, Park, SH, Kim, JY, Nam, SJ, Lee, JE, Kim, SW, Lee, SK, Im, SA, Kim, MS, Kim, TY, Oh, DY, Lee, KH, Lee, DW, Kim, HJ, Jung, KH, Kim, SB, Ahn, JH, Kim, JE, Jung, JH, Kang, SY, Ahn, MS, Choi, YW, Kim, GM, Sohn, JH, Kim, MH, Koh, SJ, Cheon, JK, Lee, JI, Lim, ST, Hyun, SY, Lee, KE, Lee, MH, Cho, JH, Lim, JH, Park, Yeon Hee, Kim, Tae-Yong, Kim, Gun Min, Kang, Seok Yun, Park, In Hae, Kim, Jee Hyun, Lee, Kyoung Eun, Ahn, Hee Kyung, Lee, Moon Hee, Kim, Hee-Jun, Kim, Han Jo, Lee, Jong In, Koh, Su-Jin, Kim, Ji-Yeon, Lee, Kyung-Hun, Sohn, Joohyuk, Kim, Sung-Bae, Ahn, Jin-Seok, Im, Young-Hyuck, Jung, Kyung Hae, and Im, Seock-Ah

Published
2019
Full Text
View/download PDF

18. Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD‐VTE patients

Author

Haas, Sylvia, Ageno, Walter, Weitz, Jeffrey I., Goldhaber, Samuel Z., Turpie, Alexander G.G., Goto, Shinya, Angchaisuksiri, Pantep, Dalsgaard Nielsen, Joern, Kayani, Gloria, Zaghdoun, Audrey, Farjat, Alfredo E., Schellong, Sebastian, Bounameaux, Henri, Mantovani, Lorenzo G., Prandoni, Paolo, Kakkar, Ajay K., Loualidi, Ab, Colak, Abdurrahim, Bezuidenhout, Abraham, Abdool‐Carrim, Abu, Azeddine, Addala, Beyers, Adriaan, Dees, Adriaan, Mohamed, Ahmed, Aksoy, Ahmet, Abiko, Akihiko, Watanabe, Akinori, Krichell, Alan, Fernandez, Alberto Alfredo, Tosetto, Alberto, Khotuntsov, Alexey, Oropallo, Alisha, Slocombe, Alison, Kelly, Allan, Clark, Amanda, Gad, Amr, Arouni, Amy, Schmidt, Andor, Berni, Andrea, Kleiban, Andres Javier, Machowski, Andrew, Kazakov, Andrey, Galvez, Angel, Lockman, Ann, Falanga, Anna, Chauhan, Anoop, Riera‐Mestre, Antoni, Mazzone, Antonino, D'Angelo, Armando, Herdy, Artur, Kato, Atsushi, Ebrahim, Ayman Abd Elhamid, Salem, Mahmoud, Husin, Azlan, Erdelyi, Barbara, Jacobson, Barry, Amann‐Vesti, Beatrice, Battaloglu, Bektas, Wilson, Benedicte, Cosmi, Benilde, Francois, Bergmann Jean, Toufek, Berremeli, Hunt, Beverley, Natha, Bhavesh, Mustafa, Bisher, Kho, Bonnie Chi Shan, Carine, Boulon, Zidel, Brian, Dominique, Brisot, Christophe, Brousse, Trimarco, Bruno, Luo, Canhua, Alberto Cuneo, Carlos, Sanchez Diaz, Carlos Jerjes, Schwencke, Carsten, Cader, Cas, Yavuz, Celal, Javier Zaidman, Cesar, Lunn, Charles, Wu, Chau‐Chung, Toh, Cheng Hock, Chiang, Chern‐En, Elisa, Chevrier, Hsia, Chien‐Hsun, Huang, Chien‐Lung, Kwok, Chi‐Hang Kevin, Wu, Chih‐Cheng, Huang, Chi‐Hung, Ward, Chris, Opitz, Christian, Jeanneret‐Gris, Christina, Ha, Chung Yin, Huang, Chun‐Yao, Bidi, Claude Luyeye, Smith, Clifford, Brauer, Cornelia, Lodigiani, Corrado, Francis, Couturaud, Wu, Cynthia, Staub, Daniel, Theodoro, Daniel, Poli, Daniela, Acevedo, Riesco, Adler, David, Jimenez, David, Keeling, David, Scott, David, Imberti, Davide, Creagh, Desmond, Helene, Desmurs‐Clavel, Hagemann, Dirk, Le Roux, Dirk, Skowasch, Dirk, Belenky, Dmitry, Dorokhov, Dmitry, Petrov, Dmitry, Zateyshchikov, Dmitry, Prisco, Domenico, Møller, Dorthe, Kucera, Dusan, Esheiba, Ehab M., Panchenko, Elizaveta, Dominique, Elkouri, Dogan, Emre, Kubat, Emre, Diaz Diaz, Enrique, Tse, Eric Wai Choi, Yeo, Erik, Hashas, Erman, Grochenig, Ernst, Tiraferri, Eros, Blessing, Erwin, Michèle, Escande Orthlieb, Usandizaga, Esther, Porreca, Ettore, Ferroni, Fabian, Nicolas, Falvo, Ayala‐Paredes, Félix, Koura, Firas, Henry, Fitjerald, Cosmi, Franco, Erdkamp, Frans, Kamalov, Gadel, Dalmau, Garcia‐Bragado, Damien, Garrigues, Klein, Garry, Shah, Gaurand, Hollanders, Geert, Merli, Geno, Plassmann, Georg, Platt, George, Poirier, Germain, Sokurenko, German, Haddad, Ghassan, Ali, Gholam, Agnelli, Giancarlo, Gan, Gin Gin, Kaye‐Eddie, Grace, Le Gal, Gregoire, Allen, Gregory, Llamas Esperón, Guillermo Antonio, Jean‐Paul, Guillot, Gerofke, Hagen, Elali, Hallah, Burianova, Hana, Ohler, Hans‐Juergen, Wang, Haofu, Darius, Harald, Gogia, Harinder S., Striekwold, Harry, Gibbs, Harry, Hasanoglu, Hatice, Turker, Hatice, Franow, Hendrik, De Raedt, Herbert, Schroe, Herman, ElDin, Hesham Salah, Zidan, Hesham, Nakamura, Hiroaki, Kim, Ho Young, Lawall, Holger, Zhu, Hong, Tian, Hongyan, Yhim, Ho‐Young, ten Cate, Hugo, Hwang, Hun Gyu, Shim, Hyeok, Kim, Igor, Libov, Igor, Sonkin, Igor, Suchkov, Igor, Song, Ik‐Chan, Kiris, Ilker, Staroverov, Ilya, Looi, Irene, De La Azuela Tenorio, Isabel M, Savas, Ismail, Gordeev, Ivan, Podpera, Ivo, Lee, Jae Hoon, Sathar, Jameela, Welker, James, Beyer‐Westendorf, Jan, Kvasnicka, Jan, Vanwelden, Jan, Kim, JangYong, Svobodova, Jaromira, Gujral, Jaspal, Marino, Javier, Galvar, Javier Tristan, Kassis, Jeannine, Kuo, Jen‐Yuan, Shih, Jhih‐Yuan, Kwon, JiHyun, Joh, Jin Hyun, Park, Jin Hyun, Kim, Jin Seok, Yang, Jinghua, Krupicka, Jiri, Lastuvka, Jiri, Pumprla, Jiri, Vesely, Jiri, Carlos Souto, Joan, Antônio Correa, João, Duchateau, Johan, Fletcher, John Perry, del Toro, Jorge, Chavez Paez, Jorge Guillermo, Araujo Filho, Jose Dalmo, Saraiva, Jose, Diaz Peromingo, Jose Antonio, Gomez Lara, Jose, Luis Fedele, Jose, Maria Surinach, Jose, Chacko, Joseph, Antonio Muntaner, Juan, Álvarez Benitez, Juan Carlos, Hoyos Abril, Juan Moreno, Humphrey, Julian, Bono, Julio, Kanda, Junji, Boondumrongsagoon, Juree, Yiu, Kai Hang, Chansung, Kanchana, Boomars, Karin, Burbury, Kate, Kondo, Katsuhiro, Karaarslan, Kemal, Takeuchi, Kensuke, Kroeger, Knut, Zrazhevskiy, Konstantin, Svatopluk, Koscál, Shyu, Kou‐Gi, Vandenbosch, Kristel, Chang, Kuan‐Cheng, Chiu, Kuan‐Ming, Jean‐Manuel, Kubina, Wern, Kwan Jing, Ueng, Kwo‐Chang, Norasetthada, Lalita, Binet, Laure, Chew, Lee Ping, Zhang, Lei, Cristina, Leone Maria, Tick, Lidwine, Beatriz Schiavi, Lilia, Wong, Lily Lee Lee, Borges, Lohana, Botha, Louis, Capiau, Luc, Timmermans, Luc, Eduardo López, Luciano, Ria, Luigi, Hernandez Blasco, Luis Manuel, Guzman, Luis Alberto, Flota Cervera, Luis, Isabelle, Mahe, Monreal Bosch, Manuel, de los Rios Ibarra, Manuel, Núñez Fernandez, Manuel, Carrier, Marc, Raul Barrionuevo, Marcelo, Alcocer Gamba, Marco Antonio, Cattaneo, Marco, Moia, Marco, Bowers, Margaret, Chetanachan, Mariam, Berli, Mario Alberto, Fixley, Mark, Faghih, Markus, Stuecker, Markus, Schul, Marlin, Banyai, Martin, Koretzky, Martin, Myriam, Martin, Gaffney, Mary Elizabeth, Hirano, Masao, Kanemoto, Masashi, Nakamura, Mashio, Tahar, Mersel, Emmanuel, Messas, Kovacs, Michael, Leahy, Michael, Levy, Michael, Munch, Michael, Olsen, Michael, De Pauw, Michel, Gustin, Michel, Van Betsbrugge, Michiel, Boyarkin, Mikhail, Homza, Miroslav, Koto, Modise, Abdool‐Gaffar, Mohamed, Nagib, Mohamed Ayman Fakhry, El‐Dessoki, Mohamed, Khan, Mohamed, Mohamed, Monniaty, Kim, Moo Hyun, Lee, Moon‐Hee, Soliman, Mosaad, Ahmed, Mostafa Shawky, el Bary, Mostafa Soliman Abd, Moustafa, Moustafa A., Hameed, Muhammad, Kanko, Muhip, Majumder, Mujibur, Zubareva, Nadezhda, Mumoli, Nicola, Abdullah, Nik Azim Nik, Makruasi, Nisa, Paruk, Nishen, Kanitsap, Nonglak, Duda, Norberto, Nordin, Nordiana, Nyvad, Ole, Barbarash, Olga, Gurbuz, Orcun, Vilamajo, Oscar Gomez, Nandayapa Flores, Oscar, Gur, Ozcan, Oto, Oztekin, Javier Marchena, Pablo, Carroll, Patrick, Lang, Pavel, MacCallum, Peter, von Bilderling, Peter Baron, Blombery, Peter, Verhamme, Peter, Jansky, Petr, Bernadette, Peuch, De Vleeschauwer, Philippe, Hainaut, Philippe, Ferrini, Piera Maria, Iamsai, Piriyaporn, Christian, Ponchaux, Viboonjuntra, Pongtep, Rojnuckarin, Ponlapat, Ho, Prahlad, Mutirangura, Pramook, Wells, Rachel, Martinez, Rafael, Miranda, Raimundo Tirado, Kroening, Ralf, Ratsela, Rapule, Reyes, Raquel Lopez, Diaz de Leon, Raul Franco, Wong, Raymond Siu Ming, Alikhan, Raz, Jerwan‐Keim, Reinhold, Otero, Remedios, Murena‐Schmidt, Renate, Canevascini, Reto, Ferkl, Richard, White, Richard, Van Herreweghe, Rika, Santoro, Rita, Klamroth, Robert, Mendes, Robert, Prosecky, Robert, Cappelli, Roberto, Spacek, Rudolf, Singh, Rupesh, Griffin, Sam, Na, Sang Hoon, Chunilal, Sanjeev, Middeldorp, Saskia, Nakazawa, Satoshi, Toh, See Guan, Christophe, Seinturier, Isbir, Selim, Raymundo, Selma, Ting, Seng Kiat, Motte, Serge, Aktogu, Serir Ozkan, Donders, Servaas, Cha, Seung Ick, Nam, Seung‐Hyun, Marie‐Antoinette, Sevestre‐Pietri, Maasdorp, Shaun, Sun, Shenghua, Wang, Shenming, Essameldin, Sherif Mohamed, Sholkamy, Sherif Mohamed, Kuki, Shintaro, Yoshida, Shuichi, Matsuoka, Shunzo, McRae, Simon, Watt, Simon, Patanasing, Siriwimon, Jean‐Léopold, Siwe‐Nana, Wongkhantee, Somchai, Bang, Soo‐Mee, Testa, Sophie, Zemek, Stanislav, Behrens, Steffen, Dominique, Stephan, Mellor, Stuart, Singh, Suaran Singh Gurcharan, Datta, Sudip, Chayangsu, Sunee, Solymoss, Susan, Everington, Tamara, Abdel‐Azim, Tarek Ahmed Adel, Suwanban, Tawatchai, Adademir, Taylan, Hart, Terence, Béatrice, Terriat, Luvhengo, Thifhelimbilu, Horacek, Thomas, Zeller, Thomas, Boussy, Tim, Reynolds, Tim, Biss, Tina, Chao, Ting‐Hsing, Casabella, Tomas Smith, Onodera, Tomoya, Numbenjapon, Tontanai, Gerdes, Victor, Cech, Vladimir, Krasavin, Vladimir, Tolstikhin, Vladimir, Bax, W.A., Malek, Wagih Fawzy Abdel, Ho, Wai Khoon, Pharr, Walter, Jiang, Weihong, Lin, Wei‐Hsiang, Zhang, Weihua, Tseng, Wei‐Kung, Lai, Wen‐Ter, De Backer, Wilfried, Haverkamp, Wilhelm, Yoshida, Winston, Korte, Wolfgang, Choi, Won II, Kim, Yang‐Ki, Tanabe, Yasuhiro, Ohnuma, Yasushi, Mun, Yeung‐Chul, Balthazar, Yohan, Park, Yong, Shibata, Yoshisato, Burov, Yuriy, Subbotin, Yuriy, Coufal, Zdenek, Yang, Zhenwen, Jing, Zhicheng, and Yang, Zhongqi

Published
2019
Full Text
View/download PDF

19. Tri-band receivers for the INAF radio telescopes: from procurement to acceptance tests

Author

Bolli, Pietro, primary, Han, Seog-Tae, additional, Choi, Jihoon, additional, Orfei, Alessandro, additional, Porceddu, Ignazio, additional, Byun, Do-Young, additional, Cattani, Alessandro, additional, Chung, Moon-Hee, additional, Fiocchi, Franco, additional, Gaudiomonte, Francesco, additional, Je, Do-Heung, additional, Ladu, Adelaide, additional, Lee, Jung-Won, additional, Lee, Moon-Hee, additional, Lee, Sung-Mo, additional, Mariotti, Sergio, additional, Marongiu, Pasqualino, additional, Pisanu, Tonino, additional, Poloni, Marco, additional, Roda, Juri, additional, Scalambra, Alessandro, additional, Schirru, Renata, additional, and Goldsmith, Paul F., additional

Published
2023
Full Text
View/download PDF

21. Relationship between neutrophil gelatinase-associated lipocalin, cardiac biomarkers, inflammation index and renal parameters in cardiovascular disease

Author

Choi Jong Weon, Lee Moon Hee, and Fujii Tatsuyoshi

Subjects
neutrophil gelatinase-associated lipocalin, inflammation index, myocardial infarction, renal dysfunction, cardiac biomarkers, Biology (General), QH301-705.5
Abstract

The plasma neutrophil gelatinase-associated lipocalin (NGAL) level is elevated in myocardial infarction (MI) and affected by inflammation and kidney function. The aim of this study was to determine which of these conditions more critically affects the plasma NGAL level in MI. Patients with MI were evaluated by measuring the NGAL concentration and its corrected values. No significant association was observed between plasma NGAL concentration and cardiac biomarkers. However, the NGAL/inflammation index ratio (NGAL/Inf ratio) was positively correlated with troponin-I (r=0.289, p

Published
2019
Full Text
View/download PDF

24. Table S1 from Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma

Author

Lee, Moon Hee, primary, Theodoropoulos, Jason, primary, Huuhtanen, Jani, primary, Bhattacharya, Dipabarna, primary, Järvinen, Petrus, primary, Tornberg, Sara, primary, Nísen, Harry, primary, Mirtti, Tuomas, primary, Uski, Ilona, primary, Kumari, Anita, primary, Peltonen, Karita, primary, Draghi, Arianna, primary, Donia, Marco, primary, Kreutzman, Anna, primary, and Mustjoki, Satu, primary

Published
2023
Full Text
View/download PDF

25. Figure S15 from Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma

Author

Lee, Moon Hee, primary, Theodoropoulos, Jason, primary, Huuhtanen, Jani, primary, Bhattacharya, Dipabarna, primary, Järvinen, Petrus, primary, Tornberg, Sara, primary, Nísen, Harry, primary, Mirtti, Tuomas, primary, Uski, Ilona, primary, Kumari, Anita, primary, Peltonen, Karita, primary, Draghi, Arianna, primary, Donia, Marco, primary, Kreutzman, Anna, primary, and Mustjoki, Satu, primary

Published
2023
Full Text
View/download PDF

26. Data from Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma

Author

Lee, Moon Hee, primary, Theodoropoulos, Jason, primary, Huuhtanen, Jani, primary, Bhattacharya, Dipabarna, primary, Järvinen, Petrus, primary, Tornberg, Sara, primary, Nísen, Harry, primary, Mirtti, Tuomas, primary, Uski, Ilona, primary, Kumari, Anita, primary, Peltonen, Karita, primary, Draghi, Arianna, primary, Donia, Marco, primary, Kreutzman, Anna, primary, and Mustjoki, Satu, primary

Published
2023
Full Text
View/download PDF

27. FIGURE 1 from Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma

Author

Lee, Moon Hee, primary, Theodoropoulos, Jason, primary, Huuhtanen, Jani, primary, Bhattacharya, Dipabarna, primary, Järvinen, Petrus, primary, Tornberg, Sara, primary, Nísen, Harry, primary, Mirtti, Tuomas, primary, Uski, Ilona, primary, Kumari, Anita, primary, Peltonen, Karita, primary, Draghi, Arianna, primary, Donia, Marco, primary, Kreutzman, Anna, primary, and Mustjoki, Satu, primary

Published
2023
Full Text
View/download PDF

28. FIGURE 2 from Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma

Author

Lee, Moon Hee, primary, Theodoropoulos, Jason, primary, Huuhtanen, Jani, primary, Bhattacharya, Dipabarna, primary, Järvinen, Petrus, primary, Tornberg, Sara, primary, Nísen, Harry, primary, Mirtti, Tuomas, primary, Uski, Ilona, primary, Kumari, Anita, primary, Peltonen, Karita, primary, Draghi, Arianna, primary, Donia, Marco, primary, Kreutzman, Anna, primary, and Mustjoki, Satu, primary

Published
2023
Full Text
View/download PDF

29. FIGURE 3 from Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma

Author

Lee, Moon Hee, primary, Theodoropoulos, Jason, primary, Huuhtanen, Jani, primary, Bhattacharya, Dipabarna, primary, Järvinen, Petrus, primary, Tornberg, Sara, primary, Nísen, Harry, primary, Mirtti, Tuomas, primary, Uski, Ilona, primary, Kumari, Anita, primary, Peltonen, Karita, primary, Draghi, Arianna, primary, Donia, Marco, primary, Kreutzman, Anna, primary, and Mustjoki, Satu, primary

Published
2023
Full Text
View/download PDF

30. FIGURE 6 from Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma

Author

Lee, Moon Hee, primary, Theodoropoulos, Jason, primary, Huuhtanen, Jani, primary, Bhattacharya, Dipabarna, primary, Järvinen, Petrus, primary, Tornberg, Sara, primary, Nísen, Harry, primary, Mirtti, Tuomas, primary, Uski, Ilona, primary, Kumari, Anita, primary, Peltonen, Karita, primary, Draghi, Arianna, primary, Donia, Marco, primary, Kreutzman, Anna, primary, and Mustjoki, Satu, primary

Published
2023
Full Text
View/download PDF

31. FIGURE 5 from Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma

Author

Lee, Moon Hee, primary, Theodoropoulos, Jason, primary, Huuhtanen, Jani, primary, Bhattacharya, Dipabarna, primary, Järvinen, Petrus, primary, Tornberg, Sara, primary, Nísen, Harry, primary, Mirtti, Tuomas, primary, Uski, Ilona, primary, Kumari, Anita, primary, Peltonen, Karita, primary, Draghi, Arianna, primary, Donia, Marco, primary, Kreutzman, Anna, primary, and Mustjoki, Satu, primary

Published
2023
Full Text
View/download PDF

32. FIGURE 4 from Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma

Author

Lee, Moon Hee, primary, Theodoropoulos, Jason, primary, Huuhtanen, Jani, primary, Bhattacharya, Dipabarna, primary, Järvinen, Petrus, primary, Tornberg, Sara, primary, Nísen, Harry, primary, Mirtti, Tuomas, primary, Uski, Ilona, primary, Kumari, Anita, primary, Peltonen, Karita, primary, Draghi, Arianna, primary, Donia, Marco, primary, Kreutzman, Anna, primary, and Mustjoki, Satu, primary

Published
2023
Full Text
View/download PDF

33. Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma

Author

Lee, Moon Hee, primary, Theodoropoulos, Jason, additional, Huuhtanen, Jani, additional, Bhattacharya, Dipabarna, additional, Järvinen, Petrus, additional, Tornberg, Sara, additional, Nísen, Harry, additional, Mirtti, Tuomas, additional, Uski, Ilona, additional, Kumari, Anita, additional, Peltonen, Karita, additional, Draghi, Arianna, additional, Donia, Marco, additional, Kreutzman, Anna, additional, and Mustjoki, Satu, additional

Published
2023
Full Text
View/download PDF

34. Table S1 from Immunological characterization and T-cell receptor repertoires of expanded tumor-infiltrating lymphocytes in renal cell carcinoma patients

Author

Lee, Moon Hee, primary, Theodoropoulos, Jason, primary, Huuhtanen, Jani, primary, Bhattacharya, Dipabarna, primary, Järvinen, Petrus, primary, Tornberg, Sara, primary, Nísen, Harry, primary, Mirtti, Tuomas, primary, Uski, Ilona, primary, Kumari, Anita, primary, Peltonen, Karita, primary, Draghi, Arianna, primary, Donia, Marco, primary, Kreutzman, Anna, primary, and Mustjoki, Satu, primary

Published
2023
Full Text
View/download PDF

35. Figure S12 from Immunological characterization and T-cell receptor repertoires of expanded tumor-infiltrating lymphocytes in renal cell carcinoma patients

Author

Lee, Moon Hee, primary, Theodoropoulos, Jason, primary, Huuhtanen, Jani, primary, Bhattacharya, Dipabarna, primary, Järvinen, Petrus, primary, Tornberg, Sara, primary, Nísen, Harry, primary, Mirtti, Tuomas, primary, Uski, Ilona, primary, Kumari, Anita, primary, Peltonen, Karita, primary, Draghi, Arianna, primary, Donia, Marco, primary, Kreutzman, Anna, primary, and Mustjoki, Satu, primary

Published
2023
Full Text
View/download PDF

36. Data from Immunological characterization and T-cell receptor repertoires of expanded tumor-infiltrating lymphocytes in renal cell carcinoma patients

Author

Lee, Moon Hee, primary, Theodoropoulos, Jason, primary, Huuhtanen, Jani, primary, Bhattacharya, Dipabarna, primary, Järvinen, Petrus, primary, Tornberg, Sara, primary, Nísen, Harry, primary, Mirtti, Tuomas, primary, Uski, Ilona, primary, Kumari, Anita, primary, Peltonen, Karita, primary, Draghi, Arianna, primary, Donia, Marco, primary, Kreutzman, Anna, primary, and Mustjoki, Satu, primary

Published
2023
Full Text
View/download PDF

37. Real-world safety and effectiveness of CT-P6 (biosimilar trastuzumab): A post-marketing surveillance study in Korea.

Author

Park, Min-Ho, primary, Kim, Tea Hyun, additional, Seo, Jae Hong, additional, Park, Jung Ho, additional, Seong, Min-Ki, additional, Park, Keon Uk, additional, Kim, Min Kyoon, additional, Chang, Myungchul, additional, Koh, Su-Jin, additional, Lee, Moon Hee, additional, Lim, Seung Taek, additional, Yoo, Young Bum, additional, Oh, So Yeon, additional, Kim, Sung Hyun, additional, Park, Tae Hong, additional, Ju, Hana, additional, Baek, Eric Hyungseok, additional, Kim, Sinhye, additional, Kim, Nahyun, additional, and Lee, Eunkyung, additional

Published
2023
Full Text
View/download PDF

38. Efficacy and safety of biosimilar trastuzumab (CT-P6) in routine clinical practice in the Republic of Korea: a real-world post-marketing surveillance study

Author

Park, Min Ho, Seo, Jae Hong, Park, Jung Ho, Seong, Min-Ki, Park, Keon Uk, Kim, Min Kyoon, Chang, Myungchul, Koh, Su-Jin, Lee, Moon Hee, Lim, Seung Taek, Yoo, Young Bum, Oh, So Yeon, Kim, Sung Hyun, Ahn, Keum Young, Park, Tae Hong, Ju, Hana, Baek, Eric Hyungseok, Kim, Sinhye, Kim, Nahyun, Lee, Eunkyung, and Kim, Tae Hyun

Abstract

ABSTRACTBackgroundThe trastuzumab biosimilar CT-P6 is approved for human epidermal growth factor receptor 2 (HER2)–positive early breast cancer (EBC), metastatic breast cancer (MBC), and metastatic gastric cancer (MGC). The objective of this post-marketing surveillance (PMS) study was to evaluate the real-world safety and effectiveness of CT-P6 in patients with HER2-positive cancers.Research design and methodsThis open-label, observational, prospective, PMS study collected data via investigator surveys from 35 centers in the Republic of Korea (5 October 2018–4 October 2022). Eligible patients with HER2-positive EBC, MBC, or MGC started CT-P6 treatment during routine clinical practice, followed by 1-year observation. Evaluations included adverse events (AEs), adverse drug reactions (ADRs), and effectiveness.ResultsSafety was analyzed in 642 patients (494 EBC, 94 MBC, 54 MGC). Overall, 325 (50.6%) patients experienced 1316 AEs, and 550 ADRs occurred in 199 (31.0%) patients. Unexpected ADRs occurred in 62 (9.7%) patients. Unexpected ADRs and ADRs of special interest did not raise any new safety signals. Among trastuzumab-naïve patients, 34/106 (32.1%) with EBC achieved pathological complete response; 30/74 (40.5%) MBC and 24/49 (49.0%) MGC patients achieved complete or partial response.ConclusionsIn a real-world setting, CT-P6 demonstrated safety and efficacy findings consistent with previous CT-P6 studies.

Published
2024
Full Text
View/download PDF

43. The immunological profile of renal cell carcinoma patients

Author

Lee, Moon Hee, University of Helsinki, Faculty of Medicine, Translational immunology research program (TRIMM), Doctoral Program in Clinical Research, Helsingin yliopisto, lääketieteellinen tiedekunta, Kliininen tohtoriohjelma, Helsingfors universitet, medicinska fakulteten, Doktorandprogrammet i klinisk forskning, Koivunen, Jussi, Mustjoki, Satu, and Kreutzman, Anna

Subjects
clinical research
Abstract

Renal cell carcinoma (RCC) is a highly immune infiltrated tumor that is known to be resistant to conventional chemo- and radiotherapies. This study aims to characterize the immune landscape of RCC, focusing on tumor-infiltrating lymphocytes (TILs) and their interactions in the tumor microenvironment (TME). The origin, immunological phenotype, and T-cell receptor (TCR) specificities of RCC TILs were evaluated using functional assays and sequencing techniques. First, primary tumors, adjacent healthy renal tissue, and peripheral blood (PB) were collected from RCC patients. Flow cytometry, multiplexed immunohistochemistry (mIHC), RNA-sequencing (RNA-seq), and mutation gene panel analysis identified two RCC tumor subgroups: CD3+ T-cell (CD3high) and natural killer (NK) cell (NKhigh) abundant tumors. Higher NK-cell infiltration was associated with lower TIL abundance and decreased PD-1 expression. Next, we focused on cytokine expression profiles in RCC tumors. Tumor and healthy tissue samples were analyzed for 42 cytokines using a multiplexed immunoassay. Significant differences in cytokine expression were observed between tumor and healthy tissue. Correlations between cytokines and TIL immunophenotype were determined. Tumor samples clustered into three distinct cytokine profiles (high, intermediate, low), with positive correlations between TILs and CXCL9/CXCL10 chemokines. Lastly, we examined the differences between minimally cultured "pre-rapidly expanded" TILs (pre-REP), and "rapidly expanded" TILs (REP) obtained from primary tumor tissue, using a clinical grade protocol. Immunophenotyping of pre-REP and REP TILs revealed immunological differences in the T-cells. TIL-tumor co-culture assays were carried out to measure IFNγ and TNFα expressions, giving further insights to the immunomodulatory effects of the TME. Bulk TCRb-sequencing and single-cell RNA-sequencing identified distinct differences in TCR repertoires and clonotypes among the TILs based on the TME. In conclusion, this study provides a comprehensive understanding of the immune profile in RCC patients, potentially leading to novel prognostic biomarkers. The findings elucidate the complex interactions between TILs and the TME, offering insights for immunotherapeutic strategies to improve RCC patient outcomes. Munuaiskarsinooman eli munuaissyövän (RCC) tiedetään olevan vastustuskykyinen perinteisille syövän hoitomuodoille, kuten sädehoidolle ja kemoterapialle. Tässä tutkimuksessa pyrimme ymmärtämään, miten immuunijärjestelmä vuorovaikuttaa munuaiskarsinooma kasvainten kanssa, keskittyen erityisesti tiettyihin kasvaimeen tunkeutuviin immuunisoluihin, joita kutsutaan myös TIL-soluiksi. Nämä TIL-solut toimivat tärkeässä roolissa kasvaimen mikroympäristössä, ja kykenevät tunnistamaan ja hyökkäämään syöpäsoluja vastaan. Tutkimme munuaiskarsinooman ja immuunijärjestelmän solujen vuorovaikutusta kolmessa eri osassa. Ensimmäisessä osassa keräsimme näytteitä munuaiskarsinoomapotilailta ja analysoimme niitä useilla kehittyneillä tekniikoilla. Huomasimme, että munuaiskarsinoomakasvaimissa on kaksi erilaista alaryhmää, jotka riippuvat kahden immuunisolu-tyypin, CD3+ T-solujen ja luonnollisten tappajasolujen (NK-solut), runsaudesta kasvaimen sisällä. Mielenkiintoista oli, että kasvaimissa, joissa oli paljon NK-soluja, oli vähemmän TIL-soluja ja ne myös ilmensivät vähemmän PD-1 molekyyliä, joka on tärkeä syöpäsoluja tuhoavassa immuunivasteessa. Toisessa osassa tutkimme erilaisten signaalimolekyylien, sytokiinien, tasoja munuaiskarsinoomakasvaimissa ja terveissä munuaiskudoksissa. Huomasimme selkeitä eroja näiden sytokiinien ilmentymisessä kasvainten ja terveiden kudosnäytteiden välillä. Yhdistämällä nämä löydökset TIL-solujen ominaisuuksiin tunnistimme kolme erilaista sytokiinien ilmentymismallia kasvaimissa. Lisäksi löysimme yhteyksiä tiettyjen sytokiinien ja TIL-solujen määrien välillä. Kolmannessa osassa syvennyimme enemmän kasvaimista eristettyjen TIL-solujen eroihin munuaissyöpäpotilailta kasvattamalla niitä laboratoriossa kokeellisin menetelmin. Vertailimme näiden TIL-solujen immunologisia piirteitä tuoreeltaan ennen kasvatusta ja sen jälkeen. Lisäksi suoritimme toiminnallisia kokeita havaitaksemme, miten nämä kasvatetut TIL-solut vuorovaikuttivat kasvainsolujen kanssa. Edistyneiden sekvensointimenetelmien avulla tunnistimme muutoksia TIL-solujen T-solureseptoreissa eri näytteistä. Kaiken kaikkiaan tämä tutkimus tarjoaa paremman ymmärryksen siitä, miten immuunijärjestelmä reagoi munuaiskarsinoomakasvaimiin. Paljastamalla monimutkaiset vuorovaikutusmekanismit TIL-solujen ja kasvaimen mikroympäristön välillä toivomme löytävämme uusia biomerkkiaineita, jotka voivat auttaa ennustamaan munuaiskarsinoomapotilaiden hoitoennustetta. Nämä löydökset voivat myös avata tien uusille immunoterapeuttisille hoitomuodoille parantamaan munuaiskarsinoomapotilaiden ennustetta.

Published
2023

47. Efficacy and tolerability of ramucirumab monotherapy or in combination with paclitaxel in gastric cancer patients from the Expanded Access Program Cohort by the Korean Cancer Study Group (KCSG)

Author

Jung, Minkyu, Ryu, Min-Hee, Oh, Do Youn, Kang, Myounghee, Zang, Dae Young, Hwang, In Gyu, Lee, Keun-Wook, Kim, Ki Hyang, Shim, Byoung Yong, Song, Eun Kee, Sym, Sun Jin, Han, Hye Sook, Park, Young Lee, Kim, Jin Soo, Lee, Hyun Woo, Lee, Moon Hee, Koo, Dong-Hoe, Song, Hong Suk, Lee, Namsu, Yang, Sung Hyun, Choi, Dae Ro, Hong, Young Seon, Lee, Kyoung Eun, Maeng, Chi Hoon, Baek, Jin Ho, Kim, Samyong, Kim, Yeul Hong, Rha, Sun Young, Cho, Jae Yong, and Kang, Yoon-Koo

Published
2018
Full Text
View/download PDF

50. 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE

Author

Turpie, Alexander G.G., primary, Farjat, Alfredo E., additional, Haas, Sylvia, additional, Ageno, Walter, additional, Weitz, Jeffrey I., additional, Goldhaber, Samuel Z., additional, Goto, Shinya, additional, Angchaisuksiri, Pantep, additional, Kayani, Gloria, additional, Lopes, Renato D., additional, Chiang, Chern-En, additional, Gibbs, Harry, additional, Tse, Eric, additional, Verhamme, Peter, additional, ten Cate, Hugo, additional, Muntaner, Juan, additional, Schellong, Sebastian, additional, Bounameaux, Henri, additional, Prandoni, Paolo, additional, Maheshwari, Uma, additional, Kakkar, Ajay K., additional, Loualidi, Ab, additional, Colak, Abdurrahim, additional, Bezuidenhout, Abraham, additional, Abdool-Carrim, Abu, additional, Azeddine, Addala, additional, Beyers, Adriaan, additional, Dees, Adriaan, additional, Mohamed, Ahmed, additional, Aksoy, Ahmet, additional, Abiko, Akihiko, additional, Watanabe, Akinori, additional, Krichell, Alan, additional, Fernandez, Alberto Alfredo, additional, Tosetto, Alberto, additional, Khotuntsov, Alexey, additional, Oropallo, Alisha, additional, Slocombe, Alison, additional, Kelly, Allan, additional, Clark, Amanda, additional, Gad, Amr, additional, Arouni, Amy, additional, Schmidt, Andor, additional, Berni, Andrea, additional, Kleiban, Andres Javier, additional, Machowski, Andrew, additional, Kazakov, Andrey, additional, Galvez, Angel, additional, Lockman, Ann, additional, Falanga, Anna, additional, Chauhan, Anoop, additional, Riera-Mestre, Antoni, additional, Mazzone, Antonino, additional, D'Angelo, Armando, additional, Herdy, Artur, additional, Kato, Atsushi, additional, Salem, Ayman Abd Elhamid Ebrahim Mahmoud, additional, Husin, Azlan, additional, Erdelyi, Barbara, additional, Jacobson, Barry, additional, Amann-Vesti, Beatrice, additional, Battaloglu, Bektas, additional, Wilson, Benedicte, additional, Cosmi, Benilde, additional, Francois, Bergmann Jean, additional, Toufek, Berremeli, additional, Hunt, Beverley, additional, Natha, Bhavesh, additional, Mustafa, Bisher, additional, Kho, Bonnie Chi Shan, additional, Carine, Boulon, additional, Zidel, Brian, additional, Dominique, Brisot, additional, Christophe, Brousse, additional, Trimarco, Bruno, additional, Luo, Canhua, additional, Cuneo, Carlos Alberto, additional, Diaz, Carlos Jerjes Sanchez, additional, Schwencke, Carsten, additional, Cader, Cas, additional, Yavuz, Celal, additional, Zaidman, Cesar Javier, additional, Lunn, Charles, additional, Wu, Chau-Chung, additional, Toh, Cheng Hock, additional, Elisa, Chevrier, additional, Hsia, Chien-Hsun, additional, Huang, Chien-Lung, additional, Kwok, Chi-Hang Kevin, additional, Wu, Chih-Cheng, additional, Huang, Chi-Hung, additional, Ward, Chris, additional, Opitz, Christian, additional, Jeanneret-Gris, Christina, additional, Ha, Chung Yin, additional, Huang, Chun-Yao, additional, Bidi, Claude Luyeye, additional, Smith, Clifford, additional, Brauer, Cornelia, additional, Lodigiani, Corrado, additional, Francis, Couturaud, additional, Wu, Cynthia, additional, Staub, Daniel, additional, Theodoro, Daniel, additional, Poli, Daniela, additional, Acevedo, David - Riesco, additional, Adler, David, additional, Jimenez, David, additional, Keeling, David, additional, Scott, David, additional, Imberti, Davide, additional, Creagh, Desmond, additional, Helene, Desmurs-Clavel, additional, Hagemann, Dirk, additional, Le Roux, Dirk, additional, Skowasch, Dirk, additional, Belenky, Dmitry, additional, Dorokhov, Dmitry, additional, Petrov, Dmitry, additional, Zateyshchikov, Dmitry, additional, Prisco, Domenico, additional, Møller, Dorthe, additional, Kucera, Dusan, additional, Esheiba, Ehab M., additional, Panchenko, Elizaveta, additional, Dominique, Elkouri, additional, Dogan, Emre, additional, Kubat, Emre, additional, Diaz, Enrique Diaz, additional, Tse, Eric Wai Choi, additional, Yeo, Erik, additional, Hashas, Erman, additional, Grochenig, Ernst, additional, Tiraferri, Eros, additional, Blessing, Erwin, additional, Michèle, Escande Orthlieb, additional, Usandizaga, Esther, additional, Porreca, Ettore, additional, Ferroni, Fabian, additional, Nicolas, Falvo, additional, Ayala-Paredes, Félix, additional, Koura, Firas, additional, Henry, Fitjerald, additional, Cosmi, Franco, additional, Erdkamp, Frans, additional, Kamalov, Gadel, additional, Dalmau, Garcia-Bragado, additional, Damien, Garrigues, additional, Klein, Garry, additional, Shah, Gaurand, additional, Hollanders, Geert, additional, Merli, Geno, additional, Plassmann, Georg, additional, Platt, George, additional, Poirier, Germain, additional, Sokurenko, German, additional, Haddad, Ghassan, additional, Ali, Gholam, additional, Agnelli, Giancarlo, additional, Gan, Gin Gin, additional, Kaye-Eddie, Grace, additional, Le Gal, Gregoire, additional, Allen, Gregory, additional, Esperón, Guillermo Antonio Llamas, additional, Jean-Paul, Guillot, additional, Gerofke, Hagen, additional, Elali, Hallah, additional, Burianova, Hana, additional, Ohler, Hans-Juergen, additional, Wang, Haofu, additional, Darius, Harald, additional, Gogia, Harinder S., additional, Striekwold, Harry, additional, Hasanoglu, Hatice, additional, Turker, Hatice, additional, Franow, Hendrik, additional, De Raedt, Herbert, additional, Schroe, Herman, additional, ElDin, Hesham Salah, additional, Zidan, Hesham, additional, Nakamura, Hiroaki, additional, Kim, Ho Young, additional, Lawall, Holger, additional, Zhu, Hong, additional, Tian, Hongyan, additional, Yhim, Ho-Young, additional, Hwang, Hun Gyu, additional, Shim, Hyeok, additional, Kim, Igor, additional, Libov, Igor, additional, Sonkin, Igor, additional, Suchkov, Igor, additional, Song, Ik-Chan, additional, Kiris, Ilker, additional, Staroverov, Ilya, additional, Looi, Irene, additional, De La Azuela Tenorio, Isabel M., additional, Savas, Ismail, additional, Gordeev, Ivan, additional, Podpera, Ivo, additional, Lee, Jae Hoon, additional, Sathar, Jameela, additional, Welker, James, additional, Beyer-Westendorf, Jan, additional, Kvasnicka, Jan, additional, Vanwelden, Jan, additional, Kim, JangYong, additional, Svobodova, Jaromira, additional, Gujral, Jaspal, additional, Marino, Javier, additional, Galvar, Javier Tristan, additional, Kassis, Jeannine, additional, Kuo, Jen-Yuan, additional, Shih, Jhih-Yuan, additional, Kwon, JiHyun, additional, Joh, Jin Hyun, additional, Park, Jin Hyun, additional, Kim, Jin Seok, additional, Yang, Jinghua, additional, Krupicka, Jiri, additional, Lastuvka, Jiri, additional, Pumprla, Jiri, additional, Vesely, Jiri, additional, Souto, Joan Carlos, additional, Correa, João Antônio, additional, Duchateau, Johan, additional, Fletcher, John Perry, additional, del Toro, Jorge, additional, Paez, Jorge Guillermo Chavez, additional, Nielsen, Jørn, additional, Filho, Jose Dalmo Araujo, additional, Saraiva, Jose, additional, Peromingo, Jose Antonio Diaz, additional, Lara, Jose Gomez, additional, Fedele, Jose Luis, additional, Surinach, Jose Maria, additional, Chacko, Joseph, additional, Muntaner, Juan Antonio, additional, Benitez, Juan Carlos Álvarez, additional, Abril, Juan Moreno Hoyos, additional, Humphrey, Julian, additional, Bono, Julio, additional, Kanda, Junji, additional, Boondumrongsagoon, Juree, additional, Yiu, Kai Hang, additional, Chansung, Kanchana, additional, Boomars, Karin, additional, Burbury, Kate, additional, Kondo, Katsuhiro, additional, Karaarslan, Kemal, additional, Takeuchi, Kensuke, additional, Kroeger, Knut, additional, Zrazhevskiy, Konstantin, additional, Svatopluk, Koscál, additional, Shyu, Kou-Gi, additional, Vandenbosch, Kristel, additional, Chang, Kuan-Cheng, additional, Chiu, Kuan-Ming, additional, Jean-Manuel, Kubina, additional, Wern, Kwan Jing, additional, Ueng, Kwo-Chang, additional, Norasetthada, Lalita, additional, Binet, Laure, additional, Chew, Lee Ping, additional, Zhang, Lei, additional, Cristina, Leone Maria, additional, Tick, Lidwine, additional, Schiavi, Lilia Beatriz, additional, Wong, Lily Lee Lee, additional, Borges, Lohana, additional, Botha, Louis, additional, Capiau, Luc, additional, Timmermans, Luc, additional, López, Luciano Eduardo, additional, Ria, Luigi, additional, Blasco, Luis Manuel Hernandez, additional, Guzman, Luis Alberto, additional, Cervera, Luis Flota, additional, Isabelle, Mahe, additional, Bosch, Manuel Monreal, additional, de los Rios Ibarra, Manuel, additional, Fernandez, Manuel Núñez, additional, Carrier, Marc, additional, Barrionuevo, Marcelo Raul, additional, Gamba, Marco Antonio Alcocer, additional, Cattaneo, Marco, additional, Moia, Marco, additional, Bowers, Margaret, additional, Chetanachan, Mariam, additional, Berli, Mario Alberto, additional, Fixley, Mark, additional, Faghih, Markus, additional, Stuecker, Markus, additional, Schul, Marlin, additional, Banyai, Martin, additional, Koretzky, Martin, additional, Myriam, Martin, additional, Gaffney, Mary Elizabeth, additional, Hirano, Masao, additional, Kanemoto, Masashi, additional, Nakamura, Mashio, additional, Tahar, Mersel, additional, Emmanuel, Messas, additional, Kovacs, Michael, additional, Leahy, Michael, additional, Levy, Michael, additional, Munch, Michael, additional, Olsen, Michael, additional, De Pauw, Michel, additional, Gustin, Michel, additional, Van Betsbrugge, Michiel, additional, Boyarkin, Mikhail, additional, Homza, Miroslav, additional, Koto, Modise, additional, Abdool-Gaffar, Mohamed, additional, Nagib, Mohamed Ayman Fakhry, additional, El-Dessoki, Mohamed, additional, Khan, Mohamed, additional, Mohamed, Monniaty, additional, Kim, Moo Hyun, additional, Lee, Moon-Hee, additional, Soliman, Mosaad, additional, Ahmed, Mostafa Shawky, additional, el Bary, Mostafa Soliman Abd, additional, Moustafa, Moustafa A., additional, Hameed, Muhammad, additional, Kanko, Muhip, additional, Majumder, Mujibur, additional, Zubareva, Nadezhda, additional, Mumoli, Nicola, additional, Abdullah, Nik Azim Nik, additional, Makruasi, Nisa, additional, Paruk, Nishen, additional, Kanitsap, Nonglak, additional, Duda, Norberto, additional, Nordin, Nordiana, additional, Nyvad, Ole, additional, Barbarash, Olga, additional, Gurbuz, Orcun, additional, Vilamajo, Oscar Gomez, additional, Flores, Oscar Nandayapa, additional, Gur, Ozcan, additional, Oto, Oztekin, additional, Marchena, Pablo Javier, additional, Carroll, Patrick, additional, Lang, Pavel, additional, MacCallum, Peter, additional, von Bilderling, Peter Baron, additional, Blombery, Peter, additional, Jansky, Petr, additional, Bernadette, Peuch, additional, De Vleeschauwer, Philippe, additional, Hainaut, Philippe, additional, Ferrini, Piera Maria, additional, Iamsai, Piriyaporn, additional, Christian, Ponchaux, additional, Viboonjuntra, Pongtep, additional, Rojnuckarin, Ponlapat, additional, Ho, Prahlad, additional, Mutirangura, Pramook, additional, Wells, Rachel, additional, Martinez, Rafael, additional, Miranda, Raimundo Tirado, additional, Kroening, Ralf, additional, Ratsela, Rapule, additional, Reyes, Raquel Lopez, additional, de Leon, Raul Franco Diaz, additional, Wong, Raymond Siu Ming, additional, Alikhan, Raz, additional, Jerwan-Keim, Reinhold, additional, Otero, Remedios, additional, Murena-Schmidt, Renate, additional, Canevascini, Reto, additional, Ferkl, Richard, additional, White, Richard, additional, Van Herreweghe, Rika, additional, Santoro, Rita, additional, Klamroth, Robert, additional, Mendes, Robert, additional, Prosecky, Robert, additional, Cappelli, Roberto, additional, Spacek, Rudolf, additional, Singh, Rupesh, additional, Griffin, Sam, additional, Na, Sang Hoon, additional, Chunilal, Sanjeev, additional, Middeldorp, Saskia, additional, Nakazawa, Satoshi, additional, Toh, See Guan, additional, Christophe, Seinturier, additional, Isbir, Selim, additional, Raymundo, Selma, additional, Ting, Seng Kiat, additional, Motte, Serge, additional, Aktogu, Serir Ozkan, additional, Donders, Servaas, additional, Cha, Seung Ick, additional, Nam, Seung-Hyun, additional, Marie-Antoinette, Sevestre-Pietri, additional, Maasdorp, Shaun, additional, Sun, Shenghua, additional, Wang, Shenming, additional, Essameldin, Sherif Mohamed, additional, Sholkamy, Sherif Mohamed, additional, Kuki, Shintaro, additional, Yoshida, Shuichi, additional, Matsuoka, Shunzo, additional, McRae, Simon, additional, Watt, Simon, additional, Patanasing, Siriwimon, additional, Jean-Léopold, Siwe-Nana, additional, Wongkhantee, Somchai, additional, Bang, Soo-Mee, additional, Testa, Sophie, additional, Zemek, Stanislav, additional, Behrens, Steffen, additional, Dominique, Stephan, additional, Mellor, Stuart, additional, Singh, Suaran Singh Gurcharan, additional, Datta, Sudip, additional, Chayangsu, Sunee, additional, Solymoss, Susan, additional, Everington, Tamara, additional, Abdel-Azim, Tarek Ahmed Adel, additional, Suwanban, Tawatchai, additional, Adademir, Taylan, additional, Hart, Terence, additional, Béatrice, Terriat, additional, Luvhengo, Thifhelimbilu, additional, Horacek, Thomas, additional, Zeller, Thomas, additional, Boussy, Tim, additional, Reynolds, Tim, additional, Biss, Tina, additional, Chao, Ting-Hsing, additional, Casabella, Tomas Smith, additional, Onodera, Tomoya, additional, Numbenjapon, Tontanai, additional, Gerdes, Victor, additional, Cech, Vladimir, additional, Krasavin, Vladimir, additional, Tolstikhin, Vladimir, additional, Bax, W.A., additional, Malek, Wagih Fawzy Abdel, additional, Ho, Wai Khoon, additional, Pharr, Walter, additional, Jiang, Weihong, additional, Lin, Wei-Hsiang, additional, Zhang, Weihua, additional, Tseng, Wei-Kung, additional, Lai, Wen-Ter, additional, De Backer, Wilfried, additional, Haverkamp, Wilhelm, additional, Yoshida, Winston, additional, Korte, Wolfgang, additional, Choi, Won Il, additional, Kim, Yang-Ki, additional, Tanabe, Yasuhiro, additional, Ohnuma, Yasushi, additional, Mun, Yeung-Chul, additional, Balthazar, Yohan, additional, Park, Yong, additional, Shibata, Yoshisato, additional, Burov, Yuriy, additional, Subbotin, Yuriy, additional, Coufal, Zdenek, additional, Yang, Zhenwen, additional, Jing, Zhicheng, additional, and Yang, Zhongqi, additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results